Drug Profile
Research programme: Alzheimer's disease diagnostic agents - Bristol-Myers Squibb/Meso Scale Discovery
Latest Information Update: 12 Nov 2013
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 07 Nov 2013 Discontinued for Alzheimer's disease (diagnosis) in USA (unspecified route)
- 30 Mar 2012 Early research in Alzheimer's disease (diagnosis) in USA (unspecified route)